Underdog Pharmaceuticals

Pharmaceutical
Founded in 11/1/19
Mountain View, California, United States
For Profit

About Underdog Pharmaceuticals

Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 17519169 USD
  • Last Funding: 10000000 USD (Seed)
  • Funding Status: Seed

Technology Stack

Underdog Pharmaceuticals actively uses None products in their tech stack.

Market Presence

Industries: Pharmaceutical

Headquarters: Mountain View, California, United States